Baird Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $292K | Sell |
|
|||||
|
2025
Q2 | $326K | Sell |
|
|||||
|
2025
Q1 | $387K | Sell |
|
|||||
|
2024
Q4 | $478K | Sell |
|
|||||
|
2024
Q3 | $1.59M | Sell |
|
|||||
|
2024
Q2 | $1.68M | Buy |
|
|||||
|
2024
Q1 | $1.5M | Buy |
|
|||||
|
2023
Q4 | $537K | Buy |
|
|||||
|
2023
Q3 | $407K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $29.6M | Sell |
|
|||||
|
2022
Q2 | $35.9M | Buy |
|
|||||
|
2022
Q1 | $31.8M | Buy |
|
|||||
|
2021
Q4 | $330K | Sell |
|
|||||
|
2021
Q3 | $418K | Buy |
|